Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

ROADMAP is a public-private advisory partnership to evaluate the usability of multiple data sources, including real-world evidence, in the decision-making process for new treatments in Alzheimer's disease, and to advance key concepts in disease and pharmacoeconomic modeling. ROADMAP identified key disease and patient outcomes for stakeholders to make informed funding and treatment decisions, provided advice on data integration methods and standards, and developed conceptual cost-effectiveness and disease models designed in part to assess whether early treatment provides long-term benefit.

Original publication

DOI

10.3233/jad-180370

Type

Journal article

Journal

Journal of Alzheimer's disease : JAD

Publication Date

01/2019

Volume

67

Pages

495 - 501

Addresses

Department of Psychiatry, University of Oxford, Oxford, UK.

Keywords

ROADMAP Consortium